Pursuant to SEBI Circular SEBI/HO/CFD/-POD-2024/185 dated 31-12-2024 read with BSE Circular No. 20250102-4 we are submitting herewith the Integrated Filing (Financial)for the Quarter ....

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.6%Reaction day

₹47.84

prior close

₹47.84

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%-3.3% vs market

Pharmaceuticals peers, median of 161sector-0.3%-3.3% vs sector

On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 3.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.6-0.4-3.3-0.3-3.3

Next day

+1.0+1.1-0.1+0.3+0.7

+4.5+1.0+3.5+0.5+4.0

-0.3+2.6-2.9+1.9-2.2

+3.5+4.2-0.8+3.1+0.3

+6.6+4.2+2.5+3.6+3.0

+4.5-0.5+5.0+1.6+2.9

15d

-8.0+0.9-9.0+2.1-10.1

+17.3+1.5+15.9+2.5+14.9

+74.1+9.1+65.0+5.7+68.4

+67.2+8.1+59.1+7.8+59.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 161Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Colinz Laboratories Ltd has submitted its Integrated Filing (Financial) for Q4 and the full year ended 31st March 2026 to BSE, in compliance with SEBI circular requirements. The filing includes Financial Results (Annexure A) along with several standard disclosures. Annexures B through E are marked as 'Not Applicable', indicating no deviations in fund usage, no outstanding loan defaults, no reportable related party transactions, and no audit qualifications in the financial statements. The actual financial numbers and performance details are contained in Annexure A which is not included in this document. The filing was signed by Director Vijaya Mani.

Likely market impact

The 'Not Applicable' status on key annexures suggests a clean filing with no material red flags such as debt defaults, audit qualifications, or related party transaction concerns. However, actual financial performance data would be needed to assess revenue, profitability, and cash flow trends for the period.